Company:AstraZeneca Pharmaceuticals (Ireland) DAC
Legal Category:Product subject to medical prescription which may be renewed (B)
*Additional information is available within the SPC or upon request to the company
Discontinued Strength Notice
Supply of Onglyza 2.5 mg Film-Coated Tablets to the Irish market will be discontinued by July 2024.